EGLN2 Antibody
Product Specifications
Background
The hypoxia inducible factor (HIF) is a transcriptional complex that is involved in oxygen homeostasis. At normal oxygen levels, the alpha subunit of HIF is targeted for degration by prolyl hydroxylation. This gene encodes an enzyme responsible for this post-translational modification. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the upstream RAB4B (RAB4B, member RAS oncogene family) gene.
NCBI Gene ID
112398
Swiss Prot
Q96KS0
Host
Rabbit
Reactivity
Human, Mouse, Rat
Immunogen
A synthetic peptide corresponding to a sequence within amino acids 150-250 of human EGLN2 (NP_444274.1) .
Clonality
Polyclonal
Conjugation
Unconjugated
Type
Primary Antibodies
Field of Research
Cancer
Purification
Affinity purification
Positive Control
HeLa
Concentration
Batch dependent
Buffer
PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Store at -20˚ C. Avoid freeze / thaw cycles.
Calculated Molecular Weight
Observed: 43kDa
Fragment
IgG
Symbol
EGLN2
Positive Control 2
A-549
Positive Control 3
HepG2
Positive Control 4
U-87MG
Positive Control 5
MCF-7
Positive Control 6
Mouse brain
NCBI Official Name
Egl-9 family hypoxia-inducible factor 2
NCBI Organism
Homo sapiens
Other Product Names
EGLN2, EIT6, PHD1, HPH-1, HPH-3, HIFPH1, HIF-PH1
Tested Applications
WB, IP
Physical Properties
Liquid
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
